» Articles » PMID: 22798321

Lung-enriched Organisms and Aberrant Bacterial and Fungal Respiratory Microbiota After Lung Transplant

Overview
Specialty Critical Care
Date 2012 Jul 17
PMID 22798321
Citations 174
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Long-term survival after lung transplantation is limited by infectious complications and by bronchiolitis obliterans syndrome (BOS), a form of chronic rejection linked in part to microbial triggers.

Objectives: To define microbial populations in the respiratory tract of transplant patients comprehensively using unbiased high-density sequencing.

Methods: Lung was sampled by bronchoalveolar lavage (BAL) and upper respiratory tract by oropharyngeal wash (OW). Bacterial 16S rDNA and fungal internal transcribed spacer sequencing was used to profile organisms present. Outlier analysis plots defining taxa enriched in lung relative to OW were used to identify bacteria enriched in lung against a background of oropharyngeal carryover.

Measurements And Main Results: Lung transplant recipients had higher bacterial burden in BAL than control subjects, frequent appearance of dominant organisms, greater distance between communities in BAL and OW indicating more distinct populations, and decreased respiratory tract microbial richness and diversity. Fungal populations were typically dominated by Candida in both sites or by Aspergillus in BAL but not OW. 16S outlier analysis identified lung-enriched taxa indicating bacteria replicating in the lower respiratory tract. In some cases this confirmed respiratory cultures but in others revealed enrichment by anaerobic organisms or mixed outgrowth of upper respiratory flora and provided quantitative data on relative abundances of bacteria found by culture.

Conclusions: Respiratory tract microbial communities in lung transplant recipients differ in structure and composition from healthy subjects. Outlier analysis can identify specific bacteria replicating in lung. These findings provide novel approaches to address the relationship between microbial communities and transplant outcome and aid in assessing lung infections.

Citing Articles

A visualization analysis of immune-related adverse reactions in pulmonary carcinoma.

Gong Y, Kang J, Wang M, Firdaus Mohd Hayati M, Wah Goh L, Bin Syed Abdul Rahim S Hum Vaccin Immunother. 2024; 20(1):2429237.

PMID: 39588915 PMC: 11601054. DOI: 10.1080/21645515.2024.2429237.


Impact of the Lung Microbiota on Development and Progression of Lung Cancer.

Belaid A, Romeo B, Rignol G, Benzaquen J, Audoin T, Vouret-Craviari V Cancers (Basel). 2024; 16(19).

PMID: 39409962 PMC: 11605235. DOI: 10.3390/cancers16193342.


Fungal lung disease.

Jaggi T, Agarwal R, Tiew P, Shah A, Lydon E, Hage C Eur Respir J. 2024; 64(5).

PMID: 39362667 PMC: 11602666. DOI: 10.1183/13993003.00803-2024.


From bench to bedside: an interdisciplinary journey through the gut-lung axis with insights into lung cancer and immunotherapy.

Dora D, Szocs E, Soos A, Halasy V, Somodi C, Mihucz A Front Immunol. 2024; 15:1434804.

PMID: 39301033 PMC: 11410641. DOI: 10.3389/fimmu.2024.1434804.


Beyond the organ: lung microbiome shapes transplant indications and outcomes.

Ponholzer F, Bogensperger C, Krendl F, Krapf C, Dumfarth J, Schneeberger S Eur J Cardiothorac Surg. 2024; 66(4).

PMID: 39288305 PMC: 11466426. DOI: 10.1093/ejcts/ezae338.


References
1.
Botha P, Archer L, Anderson R, Lordan J, Dark J, Corris P . Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome. Transplantation. 2008; 85(5):771-4. DOI: 10.1097/TP.0b013e31816651de. View

2.
Ghannoum M, Jurevic R, Mukherjee P, Cui F, Sikaroodi M, Naqvi A . Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog. 2010; 6(1):e1000713. PMC: 2795202. DOI: 10.1371/journal.ppat.1000713. View

3.
DOvidio F, Mura M, Tsang M, Waddell T, Hutcheon M, Singer L . Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation. J Thorac Cardiovasc Surg. 2005; 129(5):1144-52. DOI: 10.1016/j.jtcvs.2004.10.035. View

4.
Munster J, van der Bij W, Breukink M, van der Steege G, Zuurman M, Hepkema B . Association between donor MBL promoter haplotype and graft survival and the development of BOS after lung transplantation. Transplantation. 2008; 86(12):1857-63. DOI: 10.1097/TP.0b013e31819064b8. View

5.
Kastelijn E, van Moorsel C, Rijkers G, Ruven H, Karthaus V, Kwakkel-Van Erp J . Polymorphisms in innate immunity genes associated with development of bronchiolitis obliterans after lung transplantation. J Heart Lung Transplant. 2010; 29(6):665-71. DOI: 10.1016/j.healun.2009.12.013. View